Identification of colorectal malignancies enabled by phasor-based autofluorescence lifetime macroimaging and ensemble learning
SignificanceColorectal cancer (CRC) remains one of the most frequent cancers and a leading contributor to cancer-associated mortality globally. CRCs are often diagnosed at an advanced stage, which leads to high mortality and morbidity. This outcome is exacerbated by high rates of recurrence and postoperative complications that contribute substantially to poor prognosis. Advancements in endoscopic assessment have improved CRC prevention, early detection, and surveillance over the years. Yet, CRC remains one of the most significant health challenges of the 21st century. Label-free optical spectroscopy methods have long been explored as potential partners to endoscopy, not only to enhance diagnostic accuracy but also to confer predictive capabilities to endoscopic evaluations.AimWe investigated the potential of time-resolved autofluorescence measurements excited at 375 and 445 nm to correctly classify benign and malignant tissues in CRC surgical specimens from 117 patients.ApproachMultiparametric autofluorescence lifetime data were collected in two distinct datasets, which were used for training (n=73) and testing (n=44) a supervised ensemble learning classification model, with standard histopathology assessment serving as ground truth.ResultsUsing 5-fold cross-validation, we achieved 82.6±0.02% sensitivity, 90.4±0.01% specificity, 87.4±0.01% accuracy, and 0.941±0.004 area under the curve (AUC) for training data. Evaluation of unseen test data yielded similar results, with 85.2% sensitivity, 84.5% specificity, 84.8% accuracy, and 0.915 AUC.ConclusionsAlthough preliminary, our findings underscore the potential impact of AI-assisted autofluorescence lifetime measurements in advancing CRC prevention, early detection, and surveillance efforts.
Authors
- Pedro Vieira (ORCID: https://orcid.org/0000-0003-0829-0746)
- Amjad C. Parvaiz (ORCID: https://orcid.org/0000-0002-4655-1006)
- Laura M. Fernández (ORCID: https://orcid.org/0000-0001-9351-0314)
- Rafaela L. Rego
- Alberto Ignacio Herrando (ORCID: https://orcid.org/0000-0001-8380-4722)
- João L. Lagarto (ORCID: https://orcid.org/0000-0001-9396-8923)
- Vladislav I. Shcheslavskiy (ORCID: https://orcid.org/0000-0003-3253-8211)
- José Azevedo (ORCID: https://orcid.org/0000-0002-2918-3088)
- Pedro G. Silva
- Hugo Domingos (ORCID: https://orcid.org/0000-0003-4161-3826)
- Mireia Castillo-Martín (ORCID: https://orcid.org/0000-0001-8926-6013)
Institutions
- Champalimaud Foundation (PT)
- Becker Technologies (Germany) (DE)
Publication Details
- Journal
- Biophotonics discovery.
- Published
- 2025-07-04
- DOI
- https://doi.org/10.1117/1.bios.2.3.032705
- Primary Topic
- Photodynamic Therapy Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- HORIZON EUROPE Marie Sklodowska-Curie Actions